The interleukin (IL)-2 family cytokines: Survival and proliferation signaling pathways in T lymphocytes

Immunological Investigations

Volumn 33, Issue 2, 2004, Pages 109-142

  Benczik, Marta ^a   Gaffen, Sarah L ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

IL 2 family; Regulation; Signaling pathways; T lymphocytes

Indexed keywords

CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 2542497114     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-120030732     Document Type: Review

References (207)

1. Akashi, K., Kondo, M., Weissman, I. L. (1998). Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol. Rev. 165:13-28.
2. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., Saltiel, A. R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
3. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., Cohen, P. (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7:261-269.
4. Asao, H., Takeshita, T., Ishii, N., Kumaki, S., Nakamura, M., Sugamura, K. (1993). Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the γ chain in two distinct signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 90:4127-4131.
5. Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., Sugamura, K. (2001). Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167:1-5.
6. Astoul, E., Edmunds, C., Cantrell, D. A., Ward, S. G. (2001). PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. Trends Immunol. 22:490-496.
7. Ayllon, V., Cayla, X., Garcia, A., Roncal, F., Fernandez, R., Albar, J. P., Martinez, C., Rebollo, A. (2001). Bcl-2 targets protein phosphatase 1 alpha to Bad. J. Immunol. 166:7345-7352.
8. Barbacid, M. (1987). Ras genes. Annu. Rev. Biochem. 56:779-827.
9. Barthel, A., Okino, S. T., Liao, J., Nakatani, K., Li, J., Whitlock, J. P. Jr., Roth, R. A. (1999). Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J. Biol. Chem. 274:20281-20286.
10. Bauer, J. H., Liu, K. D., You, Y., Lai, S. Y., Goldsmith, M. A. (1998). Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J. Biol. Chem. 273:9255-9260.
11. Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P., Crabtree, G. R. (1997). Nuclear export of NF-Atc enhanced by glycogen synthase kinase-3. Science 275:1930-1934.
12. Birkenkamp, K. U., Coffer, P. J. (2003). Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem. Soc. Trans. 31:292-297.
13. Bjorge, J. D., Jakymiw, A., Fujita, D. J. (2000). Selected glimpses into the activation and function of Src kinase. Oncogene 19:5620-5635.
14. Boise, L. H., Minn, A. J., June, C. H., Lindsten, T., Thompson, C. B. (1995). Growth factors can enhance lymphocyte survival without commiting the cell to undergo cell division. Proc. Natl. Acad. Sci. U. S. A. 92:5491-5495.
15. Bouillet, P., Metcalf, D., Huang, D. C., Tarlinton, D. M., Kay, T. W., Kontgen, F., Adams, J. M., Strasser, A. (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738.
16. Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L. C., Coultas, L., Puthalakath, H., Pellegrini, M., Cory, S., Adams, J. M., Strasser, A. (2002). BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415:922-926.
17. Brazil, D. P., Hemmings, B. A. (2001). Ten years of protein kinase B signaling: a hard Akt to follow. Trends Biochem. Sci. 26:657-664.
18. Brennan, P., Babbage, J. W., Burgering, B. M., Groner, B., Reif, K., Cantrell, D. A. (1997). Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679-689.
19. Brennan, P., Babbage, J. W., Thomas, G., Cantrell, D. (1999). p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. Mol. Cell. Biol. 19:4729-4738.
20. Brennan, P., Mehl, A. M., Jones, M., Rowe, M. (2002). Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Oncogene 21:1263-1271.
21. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857-868.
22. Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A., Greenberg, M. E. (2001). Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21:952-965.
23. Burgering, B. M., Coffer, P. J. (1995). Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602.
24. Burgering, B. M., Kops, G. J. (2002). Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27:352-360.
25. Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. Science 296:1655-1657.
26. Cantrell, D. (2002). Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14:19-26.
27. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., Reed, J. C. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321.
28. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., De Coene, C., Selz, F., Le Deist, F., Fischer, A. (1996). Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells. Blood 88:3901-3909.
29. Chan, T. O., Rittenhouse, S. E., Tsichlis, P. N. (1999). AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68:965-1014.
30. Cipres, A., Gala, S., Martinez, A. C., Merida, I., Williamson, P. (1999). An IL-2 receptor beta subdomain that controls Bcl-X(L) expression and cell survival. Eur. J. Immunol. 29:1158-1167.
31. Collado, M., Medema, R. H., Garcia-Cao, I., Dubuisson, M. L., Barradas, M., Glassford, J., Rivas, C., Burgering, B. M., Serrano, M., Lam, E. W. (2000). Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J. Biol. Chem. 275:21960-21968.
32. Comer, F. I., Parent, C. A. (2002). PI 3-kinases and PTEN: how opposites chemoattract. Cell 109:541-544.
33. Cowburn, A. S., Cadwallader, K. A., Reed, B. J., Farahi, N., Chilvers, E. R. (2002). Role of PI3-kinase-dependent Bad phosphorylation and altered transcription in cytokine-mediated neutrophil survival. Blood 100:2607-2616.
34. Cowley, S., Paterson, H., Kemp, P., Marshall, C. J. (1994). Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
35. Crawley, J. B., Willcocks, J., Foxwell, B. M. (1996). Interleukin-7 induces T cell proliferation in the absence of Erk/MAP kinase activity. Eur. J. Immunol. 26:2717-2723.
36. Crawley, J. B., Rawlinson, L., Lali, F. V., Page, T. H., Saklatvala, J., Foxwell, B. M. (1997). T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J. Biol. Chem. 272:15023-15027.
37. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., Hemmings, B. A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
38. Cuevas, B. D., Lu, Y., Mao, M., Zhang, J., LaPushin, R., Siminovitch, K., Mills, G. B. (2001). Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276:27455-27461.
39. Datta, S. R., Ranger, A. M., Lin, M. Z., Sturgill, J. F., Ma, Y. C., Cowan, C. W., Dikkes, P., Korsmeyer, S. J., Greenberg, M. E. (2002). Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell 3:631-643.
40. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., Nunez, G. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.
41. Demoulin, J. B., Uyttenhove, C., Van Roost, E., DeLestre, B., Donckers, D., Van Snick, J., Renauld, J. C. (1996). A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol. Cell. Biol. 16:4710-4716.
42. Demoulin, J. B., Van Roost, E., Stevens, M., Groner, B., Renauld, J. C. (1999). Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9. J. Biol. Chem. 274:25855-25861.
43. Demoulin, J. P., Grasso, L., Atkins, J. M., Stevens, M., Louahed, J., Levitt, R. C., Nicolaides, N. C., Renauld, J. C. (2000). Role of insulin receptor substrate-2 in interleukin-9-dependent proliferation. FEBS Lett. 482:200-204.
44. Demoulin, J. B., Van Snick, J., Renauld, J. C. (2001). Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor. Cell Growth Differ. 12:169-174.
45. Demoulin, J. B., Louahed, J., Dumoutier, L., Stevens, M., Renauld, J. C. (2003). MAP kinase activation by interleukin-9 in lymphoid and mast cell lines. Oncogene 22:1763-1770.
46. Deutsch, H. H., Koettnitz, K., Chung, J., Kalthoff, F. S. (1995). Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth. J. Immunol. 154:3696-3703.
47. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., Pandolfi, P. P. (1998). Pten is essencial for embryonic development and tumour suppression. Nat. Genet. 19:348-355.
48. Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S., Lam, E. W., Burgering, B. M., Raaijmakers, J. A., Lammers, J. W., Koenderman, L., Coffer, P. J. (2000). Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol. Cell. Biol. 20:9138-9148.
49. Dijkers, P. F., Birkenkamp, K. U., Lam, E. W., Thomas, N. S., Lammers, J. W., Koenderman, L., Coffer, P. J. (2002). FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J. Cell Biol. 156:531-542.
50. Dutil, E. M., Toker, A., Newton, A. C. (1998). Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 8:1366-1375.
51. Edinger, A. L., Thompson, C. B. (2002). Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13:2276-2288.
52. Evans, G., Goldsmith, M. A., Johnston, J. A., Xu, W., Weiler, S. R., Erwin, R., Howard, O. M. Z., Abraham, R. T., O'Shea, J. J., Greene, W. C., Farrar, W. L. (1995). Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. J. Biol. Chem. 270:28858-28863.
53. Fang, D., Wang, H. Y., Fang, N., Altman, Y., Elly, C., Liu, Y. C. (2001). Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J. Biol. Chem. 276:4872-4878.
54. Franke, T. F., Kaplan, D. R., Cantley, L. C., Toker, A. (1997). Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665-668.
55. Freeburn, R. W., Wright, K. L., Burgess, S. J., Astoul, E., Cantrell, D. A., Ward, S. G. (2002). Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J. Immunol. 169:5441-5450.
56. Friedmann, M. C., Migone, T. S., Russell, S. M., Leonard, W. J. (1996). Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. U. S. A. 93:2077-2082.
57. Fruman, D. A., Cantley, L. C. (2002). Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14:7-18.
58. Fruman, D. A., Meyers, R. E., Cantley, L. C. (1998). Phosphoinositide kinases. Annu. Rev. Biochem. 67:481-507.
59. Fruman, D. A., Snapper, S. B., Yballe, C. M., Davidson, L., Yu, J. Y., Alt, F. W., Cantley, L. C. (1999). Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 283:393-397.
60. Fujii, H., Ogasawara, K., Otsuka, H., Suzuki, M., Yamamura, K., Yokochi, T., Miyazaki, T., Suzuki, H., Mak, T. W., Taki, S., Taniguchi, T. (1998). Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations. EMBO J. 17:6551-6557.
61. Fujita, N., Sato, S., Katayama, K., Tsuruo, T. (2002). Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 277:28706-28713.
62. Furnari, F. B., Huang, H. J., Cavenee, W. K. (1998). The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58:5002-5008.
63. Gadina, M., Stancato, L. M., Bacon, C. M., Larner, A. C., O'Shea, J. J. (1998). Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. J. Immunol. 160:4657-4661.
64. Gadina, M., Sudarshan, C., Visconti, R., Zhou, Y. J., Gu, H., Neel, B. G., O'Shea, J. J. (2000). The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines. J. Biol. Chem. 275:26959-26966.
65. Gadina, M., Hilton, D., Johnston, J. A., Morinobu, A., Lighvani, A., Zhou, Y. J., Visconti, R., O'Shea, J. J. (2001). Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 13:363-373.
66. Gaffen, S. L. (2001). Signaling domains of the interleukin 2 receptor. Cytokine 14:63-77.
67. Gaffen, S. L., Lai, S. Y., Xu, W., Gouilleux, F., Groner, B., Goldsmith, M. A., Greene, W. C. (1995). Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc. Natl. Acad. Sci. U. S. A. 92:7192-7196.
68. Gaffen, S. L., Lai, S. Y., Ha, M., Liu, X., Hennighausen, L., Greene, W. C., Goldsmith, M. A. (1996). Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J. Biol. Chem. 271:21381-21390.
69. Geier, S. J., Algate, P. A., Carlberg, K., Flowers, D., Friedman, C., Trask, B., Rohrschneider, L. R. (1997). The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood 89:1876-1885.
70. Gesbert, F., Garbay, C., Bertoglio, J. (1998). Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells. J. Biol. Chem. 273:3986-3993.
71. Giallourakis, C., Kashiwada, M., Pan, P. Y., Danial, N., Jiang, H., Cambier, J., Coggeshall, K. M., Rothman, P. (2000). Positive regulation of interleukin-4-mediated proliferation by the SH2-containing inositol-5′ -phosphatase. J. Biol. Chem. 275:29275-29282.
72. Gingras, A. C., Raught, B., Sonenberg, N. (2001). Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807-826.
73. Goldsmith, M. A., Lai, S. Y., Xu, W., Amaral, M. C., Kuczek, E. S., Parent, L. J., Mills, G. B., Tarr, K. L., Longmore, G. D., Greene, W. C. (1995). Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain. J. Biol. Chem. 270:21729-21737.
74. Gonzalez-Garcia, A., Garrido, E., Hernandez, C., Alvarez, B., Jimenez, C., Cantrell, D. A., Pullen, N., Carrera, A. C. (2002). A new role for the p85-phosphatidylinositol 3-kinase regulatory subunit linking FRAP to p70 S6 kinase activation. J. Biol. Chem. 277:1500-1508.
75. Gottlieb, T. M., Leal, J. F., Seger, R., Taya, Y., Oren, M. (2002). Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 21:1299-1303.
76. Gu, H., Maeda, H., Moon, J. J., Lord, J. D., Yoakim, M., Nelson, B. H., Neel, B. G. (2000). New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20:7109-7120.
77. Han, J., Lee, J. D., Bibbs, L., Ulevitch, R. J. (1994). A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
78. Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M., McKnight, S. L. (1994). An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701-1706.
79. Huber, M., Helgason, C. D., Damen, J. E., Scheid, M., Duronio, V., Liu, L., Ware, M. D., Humphries, R. K., Krystal, G. (1999). The role of SHIP in growth factor induced signalling. Prog. Biophys. Mol. Biol. 71:423-434.
80. Ihle, J. N. (1996). Janus kinases in cytokine signalling. Philos. Trans. R. Soc. Lond., B: Biol. Sci. 351:159-166.
81. Illera, V. A., Perandones, C. E., Stunz, L. L., Mower, D. A. Jr., Ashman, R. F. (1993). Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 151:2965-2973.
82. Jiang, K., Zhong, B., Ritchey, C., Gilvary, D. L., Hong-Geller, E., Wei, S., Djeu, J. Y. (2003). Regulation of Akt-dependent cell survival by Syk and Rac. Blood 101:236-244.
83. Jimenez, C., Hernandez, C., Pimentel, B., Carrera, A. C. (2002). The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J. Biol. Chem. 277:41556-41562.
84. John, S., Robbins, C. M., Leonard, W. J. (1996). An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 15:5627-5635.
85. Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y. Q., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W., O'Shea, J. J. (1994). Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151-153.
86. Johnston, J. A., Wang, L. M., Hanson, E. P., Sun, X. J., White, M. F., Oakes, S. A., Pierce, J. H., O'Shea, J. J. (1995). Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem. 270:28527-28530.
87. Kane, L. P., Shapiro, V. S., Stokoe, D., Weiss, A. (1999). Induction of NF-kappaB by the Akt/PKB kinase. Curr. Biol. 9:601-604.
88. Kaplan, M. H., Schindler, U., Smiley, S. T., Grusby, M. J. (1996). Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-319.
89. Karnitz, L. M., Sutor, S. L., Abraham, R. T. (1994). The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line. J. Exp. Med. 179:1799-1808.
90. Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., Waterfield, M. D. (2001). Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17:615-675.
91. Keegan, A. D., Nelms, K., White, M., Wang, L. M., Pierce, J. H., Paul, W. E. (1994). An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76:811-820.
92. Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., Brasel, K., Morrissey, P. J., Stocking, K., Schuh, J. C., Joyce, S., Peschon, J. J. (2000). Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-780.
93. Khaled, A. R., Durum, S. K. (2003). Death and baxes: mechanisms of lymphotrophic cytokines. Immunol. Rev. 193:48-57.
94. Khaled, A. R., Li, W. Q., Huang, J., Fry, T. J., Khaled, A. S., Mackall, C. L., Muegge, K., Young, H. A., Durum, S. K. (2002). Bax deficiency partially corrects interleukin-7 receptor alpha deficiency. Immunity 17:561-573.
95. Klippel, A., Kavanaugh, W. M., Pot, D., Williams, L. T. (1997). A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:338-344.
96. Klippel, A., Escobedo, M. A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., Williams, L. T. (1998). Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol. 18:5699-5711.
97. Koettnitz, K., Kalthoff, F. S. (1993). Human interleukin-4 receptor signaling requires sequences contained within two cytoplasmic regions. Eur. J. Immunol. 23:988-991.
98. Koyasu, S. (2003). The role of PI3K in immune cells. Nat. Immunol. 4:313-319.
99. Krystal, G. (2000). Lipid phosphatases in the immune system. Semin. Immunol. 12:397-403.
100. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., Woodgett, J. R. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160.
101. Lai, S. Y., Xu, W., Gaffen, S. L., Liu, K. D., Longmore, G. D., Greene, W. C., Goldsmith, M. A. (1996). The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc. Natl. Acad. Sci. U. S. A. 93:231-235.
102. Lecine, P., Algarte, M., Rameil, P., Beadling, C., Bucher, P., Nabholz, M., Imbert, J. (1996). Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene. Mol. Cell. Biol. 16:6829-6840.
103. Leonard, W. J., O'Shea, J. J. (1998). Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293-322.
104. Lewis, T. S., Shapiro, P. S., Ahn, N. G. (1998). Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49-139.
105. Lin, J. X., Migone, T. S., Tsang, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S., Leonard, W. J. (1995). The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339.
106. Lindemann, M. J., Benczik, M., Gaffen, S. L. (2003). Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit. J. Biol. Chem. 278:10239-10249.
107. Liu, K. D., Gaffen, S. L., Goldsmith, M. A., Greene, W. C. (1997). Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation. Curr. Biol. 7:817-826.
108. Liu, K. D., Gaffen, S. L., Goldsmith, M. A. (1998). JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol. 10:271-278.
109. Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S., Ma, A. (1998). IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669-676.
110. Lord, J. D., McIntosh, B. C., Greenberg, P. D., Nelson, B. H. (1998). The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc. J. Immunol. 161:4627-4633.
111. Lord, J. D., McIntosh, B. C., Greenberg, P. D., Nelson, B. H. (2000). The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J. Immunol. 164:2533-2541.
112. Louahed, J., Renauld, J. C., Demoulin, J. B., Baughman, G., Bourgeois, S., Sugamura, K., Van Snick, J. (1996). Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines. J. Immunol. 156:3704-3710.
113. Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Shea, J. J. (1995). Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-68.
114. Maraskovsky, E., O'Reilly, L. A., Teepe, M., Corcoran, L. M., Peschon, J. J., Strasser, A. (1997). Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1 -/- mice. Cell 89:1011-1019.
115. March, M. E., Ravichandran, K. (2002). Regulation of the immune response by SHIP. Semin. Immunol. 14:37-47.
116. Matsuguchi, T., Inhorn, R. C., Carlesso, N., Xu, G., Druker, B., Griffin, J. D. (1995). Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J. 14:257-265.
117. Matsumura, I., Kitamura, T., Wakao, H., Tanaka, H., Hashimoto, K., Albanese, C., Downward, J., Pestell, R. G., Kanakura, Y. (1999). Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:1367-1377.
118. Mayo, L. D., Donner, D. B. (2001). A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. U. S. A. 98:11598-11603.
119. Merida, I., Williamson, P., Kuziel, W. A., Greene, W. C., Gaulton, G. N. (1993). The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. J. Biol. Chem. 268:6765-6770.
120. Migone, T. S., Lin, J. X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., Leonard, W. J. (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79-81.
121. Migone, T. S., Rodig, S., Cacalano, N. A., Berg, M., Schreiber, R. D., Leonard, W. J. (1998). Functional cooperation of the interleukin-2 receptor beta chain and Jak1 in phosphatidylinositol 3-kinase recruitment and phosphorylation. Mol. Cell. Biol. 18:6416-6422.
122. Mills, G. B., Arima, N., May, C., Hill, M., Schmandt, R., Li, J., Miyamoto, N. G., Greene, W. C. (1992). Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-1-infected human T cells. Int. Immunol. 4:1233-1243.
123. Minami, Y., Taniguchi, T. (1995). IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr. Opin. Cell Biol. 7:156-162.
124. Minami, Y., Nakagawa, Y., Kawahara, A., Miyazaki, T., Sada, K., Yamamura, H., Taniguchi, T. (1995). Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity 2:89-100.
125. Miyazaki, T., Takaoka, A., Nogueira, L., Dikic, I., Fujii, H., Tsujino, S., Mitani, Y., Maeda, M., Schlessinger, J., Taniguchi, T. (1998). Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12:770-775.
126. Moon, J. J., Nelson, B. H. (2001). Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor. J. Immunol. 167:2714-2723.
127. Moriggl, R., Topham, D. J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M. Y., Bunting, K. D., Grosveld, G. C., Ihle, J. N. (1999). Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249-259.
128. Murray, R., Suda, T., Wrighton, N., Lee, F., Zlotnik, A. (1989). IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int. Immunol. 1:526-531.
129. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., Tonks, N. K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. U. S. A. 95:13513-13518.
130. Neal, J. W., Clipstone, N. A. (2001). Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J. Biol. Chem. 276:3666-3673.
131. Nelms, K., Snow, A. L., Hu-Li, J., Paul, W. E. (1998). FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity 9:13-24.
132. Nelson, B. H., Willerford, D. M. (1998). Biology of the interleukin-2 receptor. Adv. Immunol. 70:1-81.
133. Nelson, B. H., Lord, J. D., Greenberg, P. D. (1994). Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 369:333-336.
134. Nicholson, K. M., Anderson, N. G. (2002). The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14:381-395.
135. Noguchi, M., Yi, H., Rosenblatt, H. M., Filipovich, A. H., Adelstein, S., Modi, W. S., McBride, O. W., Leonard, W. J. (1993). Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-157.
136. Oakes, S. A., Candotti, F., Johnston, J. A., Chen, Y. Q., Ryan, J. J., Taylor, N., Liu, X., Hennighausen, L., Notarangelo, L. D., Paul, W. E., Blaese, R. M., O'Shea, J. J. (1996). Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5:605-615.
137. Okkenhaug, K., Vanhaesebroeck, B. (2003). PI3K in lymphocyte development, differentiation and activation. Nat. Rev., Immunol. 3:317-330.
138. O'Shea, J. J., Gadina, M., Schreiber, R. D. (2002). Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 Suppl.:S121-S131.
139. Ott, V. L., Cambier, J. C. (2002). Multifaceted roles of lipids and their catabolites in immune cell signaling. Semin. Immunol. 14:1-6.
140. Ozaki, K., Leonard, W. J. (2002). Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 277:29355-29358.
141. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., Donner, D. B. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
142. Pages, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., Pouyssegur, J. (1993). Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. U. S. A. 90:8319-8323.
143. Pallard, C., Stegmann, A. P., van Kleffens, T., Smart, F., Venkitaraman, A., Spits, H. (1999). Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7 mediated development of human thymocyte precursors. Immunity 10:525-535.
144. Parsons, M. J., Jones, R. G., Tsao, M. S., Odermatt, B., Ohashi, P. S., Woodgett, J. R. (2001). Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. J. Immunol. 167:42-48.
145. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., Cobb, M. H. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153-183.
146. Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., Meyer, J. D., Davison, B. L. (1994). Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955-1960.
147. Pruett, W., Yuan, Y., Rose, E., Batzer, A. G., Harada, N., Skolnik, E. Y. (1995). Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Mol. Cell. Biol. 15:1778-1785.
148. Puel, A., Ziegler, S. F., Buckley, R. H., Leonard, W. J. (1998). Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 20:394-397.
149. Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., Heasley, L. E., Reusch, J. E. (2000). Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem. 275:10761-10766.
150. Quelle, F. W., Shimoda, K., Thierfelder, W., Fischer, C., Kim, A., Ruben, S. M., Cleveland, J. L., Pierce, J. H., Keegan, A. D., Nelms, K., Paul, W. E., Ihle, J. N. (1995). Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336-3343.
151. Rameh, L. E., Arvidsson, A., Carraway, K. L. III, Couvillon, A. D., Rathbun, G., Crompton, A., VanRenterghem, B., Czech, M. P., Ravichandran, K. S., Burakoff, S. J., Wang, D. S., Chen, C. S., Cantley, L. C. (1997). A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. Chem. 272:22059-22066.
152. Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H. Jr., Stephenson, J. R. (1983). Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. U. S. A. 80:4218-4222.
153. Rathmell, J. C., Farkash, E. A., Gao, W., Thompson, C. B. (2001). IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167:6869-6876.
154. Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., Thompson, C. B. (2003). Akt-directed glucose metabolism can prevent bax conformation change and promote growth factor-independent survival. Mol. Cell. Biol. 23: 7315-7328.
155. Ravichandran, K. S., Igras, V., Shoelson, S. E., Fesik, S. W., Burakoff, S. J. (1996). Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc. Natl. Acad. Sci. U. S. A. 93:5275-5280.
156. Reichel, M., Nelson, B. H., Greenberg, P. D., Rothman, P. B. (1997). The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression. J. Immunol. 158:5860-5867.
157. Reif, K., Nobes, C. D., Thomas, G., Hall, A., Cantrell, D. A. (1996). Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6:1445-1455.
158. Reif, K., Burgering, B. M., Cantrell, D. A. (1997). Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 272:14426-14433.
159. Remillard, B., Petrillo, R., Maslinski, W., Tsudo, M., Strom, T. B., Cantley, L., Varticovski, L. (1991). Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 266:14167-14170.
160. Renauld, J. C., Vink, A., Louahed, J., Van Snick, J. (1995). Interleukin-9 is a major antiapoptotic factor for thymic lymphomas. Blood 85:1300-1305.
161. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., Downward, J. (1994). Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527-532.
162. Romashkova, J. A., Makarov, S. S. (1999). NF-kappaB is a target of AKT in antiapoptotic PDGF signalling. Nature 401:86-90.
163. Romero, F., Martinez, A. C., Camonis, J., Rebollo, A. (1999). Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. EMBO J. 18:3419-3430.
164. Russell, S. M., Johnston, J. A., Noguchi, M., Kawamura, M., Bacon, C. M., Friedmann, M., Berg, M., McVicar, D. W., Witthuhn, B. A., Silvennoinen, O., Goldman, A. S., Schmalsteig, F. C., Ihle, J. N., O'Shea, J. J., Leonard, W. J. (1994). Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042-1045.
165. Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T. S., Noguchi, M., Markert, M. L., Buckley, R. H., O'Shea, J. J., Leonard, W. J. (1995). Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800.
166. Ryan, J. J., McReynolds, L. J., Keegan, A., Wang, L. H., Garfein, E., Rothman, P., Nelms, K., Paul, W. E. (1996). Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123-132.
167. Sachdev, P., Zeng, L., Wang, L. H. (2002). Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Var 3-induced cell transformation, cell motility, and morphological change. J. Biol. Chem. 277:17638-17648.
168. Sade, H., Sarin, A. (2003). IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Eur. J. Immunol. 33:913-919.
169. Schaeffer, E. M., Schwartzberg, P. L. (2000). Tec family kinases in lymphocyte signaling and function. Curr. Opin. Immunol. 12:282-288.
170. Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J., Lam, E. W., Burgering, B. M., Medema, R. H. (2002). Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol. 22:7842-7852.
171. Seger, R., Krebs, E. G. (1995). The MAPK signaling cascade. FASEB J. 9:726-735.
172. Sekulic, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., Abraham, R. T. (2000). A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60:3504-3513.
173. Seldin, D. C., Leder, P. (1994). Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. Proc. Natl. Acad. Sci. U. S. A. 91:2140-2144.
174. Sharfe, N., Roifman, C. M. (1997). Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. J. Immunol. 159:1107-1114.
175. Shin, I., Yakes, F. M., Rojo, F., Shin, N. Y., Bakin, A. V., Baselga, J., Arteaga, C. L. (2002). PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 8:1145-1152.
176. Stahl, M., Dijkers, P. F., Kops, G. J., Lens, S. M., Coffer, P. J., Burgering, B. M., Medema, R. H. (2002). The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol. 168:5024-5031.
177. Stokoe, D., Stephens, L. R., Copeland, T., Gaffney, P. R., Reese, C. B., Painter, G. F., Holmes, A. B., McCormick, F., Hawkins, P. T. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-570.
178. Storz, P., Toker, A. (2002). 3′-phosphoinositide-dependent kinase-1 (PDK-1) in PI3-kinase signaling. Front. Biosci. 7:d886-d902.
179. Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T., Koyasu, S. (1999). Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 283:390-392.
180. Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M., Tsubata, T., Ohashi, P. S., Koyasu, S., Penninger, J. M., Nakano, T., Mak, T. W. (2001). T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14:523-534.
181. Taichman, R., Merida, I., Torigoe, T., Gaulton, G. N., Reed, J. C. (1993). Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3′-kinase in interleukin-2-dependent T-cells. J. Biol. Chem. 268:20031-20036.
182. Takahashi-Tezuka, M., Hibi, M., Fujitani, Y., Fukada, T., Yamaguchi, T., Hirano, T. (1997). Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene 14:2273-2282.
183. Takeshita, T., Arita, T., Higuchi, M., Asao, H., Endo, K., Kuroda, H., Tanaka, N., Murata, K., Ishii, N., Sugamura, K. (1997). STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity 6:449-457.
184. Toker, A., Newton, A. C. (2000). Cellular signaling: pivoting around PDK-1. Cell 103:185-188.
185. Truitt, K. E., Mills, G. B., Turck, C. W., Imboden, J. B. (1994). SH2-dependent association of phosphatidylinositol 3′-kinase 85-kDa regulatory subunit with the interleukin-2 receptor beta chain. J. Biol. Chem. 269:5937-5943.
186. Tsuruta, F., Masuyama, N., Gotoh, Y. (2002). The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277:14040-14047.
187. Vanhaesebroeck, B., Alessi, D. R. (2000). The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346 Pt. 3:561-576.
188. Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., Waterfield, M. D. (1997). Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22:267-272.
189. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., Waterfield, M. D. (2001). Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:535-602.
190. Vella, A., Teague, T. K., Ihle, J., Kappler, J., Marrack, P. (1997). Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186:325-330.
191. Vella, A. T., Dow, S., Potter, T. A., Kappler, J., Marrack, P. (1998). Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 95:3810-3815.
192. Venkitaraman, A. R., Cowling, R. J. (1994). Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the alpha chain of the interleukin-7 receptor. Eur. J. Immunol. 24:2168-2174.
193. von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E., Murray, R. (1995). Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-1526.
194. Wang, H. Y., Paul, W. E., Keegan, A. D. (1996). IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4:113-121.
195. Wang, H. Y., Zamorano, J., Keegan, A. D. (1998). A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis. J. Biol. Chem. 273:9898-9905.
196. Wang, J. M., Chao, J. R., Chen, W., Kuo, M. L., Yen, J. J., Yang-Yen, H. F. (1999). The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell. Biol. 19:6195-6206.
197. Ward, S. G., Cantrell, D. A. (2001). Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol. 13:332-338.
198. Welham, M. J., Duronio, V., Leslie, K. B., Bowtell, D., Schrader, J. W. (1994). Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. J. Biol. Chem. 269:21165-21176.
199. Wilde, J. I., Watson, S. P. (2001). Regulation of phospholipase C gamma isoforms in haematopoietic cells: why one, not the other? Cell. Signal. 13:691-701.
200. Williams, M. R., Arthur, J. S., Balendran, A., van der Kaay, J., Poli, V., Cohen, P., Alessi, D. R. (2000). The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10:439-448.
201. Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., Ihle, J. N. (1993). JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236.
202. Wurster, A. L., Withers, D. J., Uchida, T., White, M. F., Grusby, M. J. (2002). Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Mol. Cell. Biol. 22:117-126.
203. Xiao, H., Yin, T., Wang, X. Y., Uchida, T., Chung, J., White, M. F., Yang, Y. C. (2002). Specificity of interleukin-2 receptor gamma chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway. J. Biol. Chem. 277:8091-8098.
204. Yin, T., Keller, S. R., Quelle, F. W., Witthuhn, B. A., Tsang, M. L., Lienhard, G. E., Ihle, J. N., Yang, Y. C. (1995). Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. J. Biol. Chem. 270:20497-20502.
205. Yin, T., Shen, R., Feng, G. S., Yang, Y. C. (1997). Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J. Biol. Chem. 272:1032-1037.
206. Zamorano, J., Wang, H. Y., Wang, L. M., Pierce, J. H., Keegan, A. D. (1996). IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157:4926-4934.
207. Zhu, Y. X., Sun, H. B., Tsang, M. L., McMahel, J., Grigsby, S., Yin, T., Yang, Y. C. (1997). Critical cytoplasmic domains of human interleukin-9 receptor alpha chain in interleukin-9-mediated cell proliferation and signal transduction. J. Biol. Chem. 272:21334-21340.